A Precautionary Approach to Touch in Psychedelic-Assisted Therapy
A spate of recent exposés have detailed the proliferation of abuse in psychedelic therapy, underscoring the urgent need for ethical guidance.

We should strive to create an academic culture where researchers consider a project’s likely impact on the world when deciding what to work on.
When science (and the media) moves this quickly, all involved should exercise a greater degree of caution when interpreting research.
As the NIH prepares for a massive influx of funding, it must follow through on its commitment to address health research funding disparities.
The doctrine of capacity is vague, normatively and medically challenging, and inconsistently applied.
Because of differences in how they were tested in clinical trials, it is difficult to make apples-to-apples comparisons for COVID-19 vaccines.
This post reflects on the ethical implications of FDA’s use of its emergency powers, and suggests opportunities for greater accountability moving forward.
A Biologics License Application, or BLA, is FDA’s standard “full approval” mechanism for biological products, including therapeutics and vaccines.